Literature DB >> 23613626

Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer.

Xue-Feng Fang1, Zhi-Bo Hou, Xin-Zheng Dai, Cong Chen, Jing Ge, Hong Shen, Xiao-Feng Li, Li-Ke Yu, Ying Yuan.   

Abstract

AIM: To evaluate the expression of special AT-rich sequence-binding protein 1 (SATB1) gene in colorectal cancer and its role in colorectal cancer cell proliferation and invasion.
METHODS: Immunohistochemistry was used to detect the protein expression of SATB1 in 30 colorectal cancer (CRC) tissue samples and pair-matched adjacent non-tumor samples. Cell growth was investigated after enhancing expression of SATB1. Wound-healing assay and Transwell assay were used to investigate the impact of SATB1 on migratory and invasive abilities of SW480 cells in vitro. Nude mice that received subcutaneous implantation or lateral tail vein were used to study the effects of SATB1 on tumor growth or metastasis in vivo.
RESULTS: SATB1 was over-expressed in CRC tissues and CRC cell lines. SATB1 promotes cell proliferation and cell cycle progression in CRC SW480 cells. SATB1 overexpression could promote cell growth in vivo. In addition, SATB1 could significantly raise the ability of cell migration and invasion in vitro and promote the ability of tumor metastasis in vivo. SATB1 could up-regulate matrix metalloproteases 2, 9, cyclin D1 and vimentin, meanwhile SATB1 could down-regulate E-cadherin in CRC.
CONCLUSION: SATB1 acts as a potential growth and metastasis promoter in CRC. SATB1 may be useful as a therapeutic target for CRC.

Entities:  

Keywords:  Colorectal cancer; Invasion; Migration; Proliferation; Special AT-rich sequence-binding protein 1

Mesh:

Substances:

Year:  2013        PMID: 23613626      PMCID: PMC3631984          DOI: 10.3748/wjg.v19.i15.2331

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  AACR special conference on epithelial-mesenchymal transition and cancer progression and treatment.

Authors:  Evanthia T Roussos; Zuzana Keckesova; John D Haley; David M Epstein; Robert A Weinberg; John S Condeelis
Journal:  Cancer Res       Date:  2010-09-07       Impact factor: 12.701

2.  Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma.

Authors:  Greg Foltz; Gi-Yung Ryu; Jae-Geun Yoon; Timothy Nelson; Jessica Fahey; Amanda Frakes; Hwahyung Lee; Lorie Field; Kaitlin Zander; Zita Sibenaller; Timothy C Ryken; Rajeev Vibhakar; Leroy Hood; Anup Madan
Journal:  Cancer Res       Date:  2006-07-01       Impact factor: 12.701

Review 3.  Matrix metalloproteinases and tumor metastasis.

Authors:  Elena I Deryugina; James P Quigley
Journal:  Cancer Metastasis Rev       Date:  2006-03       Impact factor: 9.264

4.  The role of SATB1 in breast cancer pathogenesis.

Authors:  Elizabeth Iorns; H James Hnatyszyn; Pearl Seo; Jennifer Clarke; Toby Ward; Marc Lippman
Journal:  J Natl Cancer Inst       Date:  2010-07-01       Impact factor: 13.506

5.  MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis.

Authors:  Zhibo Hou; Li Xie; Lixia Yu; Xiaoping Qian; Baorui Liu
Journal:  Med Oncol       Date:  2011-02-24       Impact factor: 3.064

6.  microRNA-146a targets the L1 cell adhesion molecule and suppresses the metastatic potential of gastric cancer.

Authors:  Zhibo Hou; Haitao Yin; Cong Chen; Xinzheng Dai; Xiaolin Li; Baorui Liu; Xuefeng Fang
Journal:  Mol Med Rep       Date:  2012-06-13       Impact factor: 2.952

Review 7.  The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis.

Authors:  A John; G Tuszynski
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

8.  Differences in the migration capacity of primary human colon carcinoma cells (SW480) and their lymph node metastatic derivatives (SW620).

Authors:  B S Kubens; K S Zänker
Journal:  Cancer Lett       Date:  1998-09-11       Impact factor: 8.679

Review 9.  The role of epithelial-mesenchymal transition in cancer pathology.

Authors:  Marcello Guarino; Barbara Rubino; Gianmario Ballabio
Journal:  Pathology       Date:  2007-06       Impact factor: 5.306

10.  Results after multivisceral resections of locally advanced colorectal cancers: an analysis on clinical and pathological t4 tumors.

Authors:  Cem Gezen; Metin Kement; Yunus E Altuntas; Nuri Okkabaz; Mesut Seker; Selahattin Vural; Mahmut Gumus; Mustafa Oncel
Journal:  World J Surg Oncol       Date:  2012-02-15       Impact factor: 2.754

View more
  13 in total

1.  Nicotinamide induces apoptosis of F9 mouse teratocarcinoma stem cells by downregulation of SATB1 expression.

Authors:  Yan Zhang; Haibo Wu; Man Zhang; Yali Jiang; Weiwei Zhuo; Yong Zhang; Song Hua
Journal:  Tumour Biol       Date:  2015-01-17

Review 2.  SATB1 and 2 in colorectal cancer.

Authors:  Jason Brocato; Max Costa
Journal:  Carcinogenesis       Date:  2014-12-27       Impact factor: 4.944

3.  Oncolytic virus carrying shRNA targeting SATB1 inhibits prostate cancer growth and metastasis.

Authors:  Li-jun Mao; Jie Zhang; Ning Liu; Li Fan; Dong-rong Yang; Bo-xin Xue; Yu-xi Shan; Jun-nian Zheng
Journal:  Tumour Biol       Date:  2015-06-19

4.  SATB1 expression is correlated with β-catenin associated epithelial-mesenchymal transition in colorectal cancer.

Authors:  Jing-huan Lv; Feng Wang; Ming-hong Shen; Xuan Wang; Xiao-jun Zhou
Journal:  Cancer Biol Ther       Date:  2016-01-25       Impact factor: 4.742

5.  Expression of p16 and SATB1 in Invasive Ductal Breast Cancer - A Preliminary Study.

Authors:  Christopher Kobierzycki; Jedrzej Grzegrzolka; Natalia Glatzel-Plucinska; Aleksandra Piotrowska; Andrzej Wojnar; Beata Smolarz; Hanna Romanowicz; Piotr Dziegiel
Journal:  In Vivo       Date:  2018 Jul-Aug       Impact factor: 2.155

6.  Divergent expression patterns of SATB1 mRNA and SATB1 protein in colorectal cancer and normal tissues.

Authors:  Anna E Kowalczyk; Janusz Godlewski; Bartlomiej E Krazinski; Jolanta Kiewisz; Agnieszka Sliwinska-Jewsiewicka; Przemyslaw Kwiatkowski; Bartosz Pula; Piotr Dziegiel; Jacek Janiszewski; Piotr M Wierzbicki; Zbigniew Kmiec
Journal:  Tumour Biol       Date:  2015-01-21

7.  SATB1 is an independent prognostic factor in radically resected upper gastrointestinal tract adenocarcinoma.

Authors:  Charlotta Hedner; Alexander Gaber; Dejan Korkocic; Björn Nodin; Mathias Uhlén; Eugenia Kuteeva; Henrik Johannesson; Karin Jirström; Jakob Eberhard
Journal:  Virchows Arch       Date:  2014-10-19       Impact factor: 4.064

8.  SATB1 Promotes Pancreatic Cancer Growth and Invasion Depending on MYC Activation.

Authors:  Zheng Chen; Zengliang Li; Wei Li; Yang Zong; Yi Zhu; Yi Miao; Zekuan Xu
Journal:  Dig Dis Sci       Date:  2015-06-25       Impact factor: 3.199

9.  Effect of silencing SATB1 on proliferation, invasion and apoptosis of A549 human lung adenocarcinoma cells.

Authors:  Bo Huang; Hongli Zhou; Siwang Wang; Xian Ping Lang; Xiaodong Wang
Journal:  Oncol Lett       Date:  2016-09-22       Impact factor: 2.967

10.  Expression of SATB1 promotes the growth and metastasis of colorectal cancer.

Authors:  Yi Zhang; Xiuyun Tian; Hong Ji; Xiaoya Guan; Wei Xu; Bin Dong; Min Zhao; Meng Wei; Chunxiang Ye; Yuan Sun; Xiaosun Yuan; Chen Yang; Chunyi Hao
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.